CollPlant Biotechnologies Ltd Payment for Contingent Consideration Liability, Investing Activities
CollPlant Biotechnologies Ltd (CLGN) had Payment for Contingent Consideration Liability, Investing Activities of $2.00 million as of 2025-02-28, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities · last filed 2026-03-26
- 2025-02-28: Payment for Contingent Consideration Liability, Investing Activities $2.00M.
| Period end | Payment for Contingent Consideration Liability, Investing Activities |
|---|---|
| 2025-02-28 | $2.00M 20-F · filed 2026-03-26 |